These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 21682553

  • 41. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.
    Looi KL, Chow KL, Looi JL, Lee M, Halliday S, White H, Ellis C.
    N Z Med J; 2011 Sep 23; 124(1343):18-27. PubMed ID: 21964009
    [Abstract] [Full Text] [Related]

  • 42. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM.
    Can J Cardiol; 2005 May 01; 21(6):485-8. PubMed ID: 15917876
    [Abstract] [Full Text] [Related]

  • 43. Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization.
    Tuppin P, Neumann A, Danchin N, de Peretti C, Weill A, Ricordeau P, Allemand H.
    Arch Cardiovasc Dis; 2010 May 01; 103(6-7):363-75. PubMed ID: 20800800
    [Abstract] [Full Text] [Related]

  • 44. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
    Milicić D.
    Acta Med Croatica; 2004 May 01; 58(2):129-34. PubMed ID: 15208798
    [Abstract] [Full Text] [Related]

  • 45. Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: results from the MITRA and MIR studies.
    Frilling B, Schiele R, Gitt AK, Zahn R, Schneider S, Glunz HG, Gieseler U, Baumgärtel B, Asbeck F, Senges J, Maximum Individual Therapy in Acute Myocardial Infarction (MITRA), Myocardial Infarction Registry (MIR) Study Groups.
    Am Heart J; 2001 Feb 01; 141(2):200-5. PubMed ID: 11174332
    [Abstract] [Full Text] [Related]

  • 46. Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromes.
    Singh SM, Goodman SG, Yan RT, Dery JP, Wong GC, Gallo R, Grondin FR, Lai K, Lopez-Sendon J, Fox KA, Yan AT, Canadian GRACE, GRACE(2) and CANRACE Investigators.
    Am J Cardiol; 2012 Feb 01; 109(3):332-6. PubMed ID: 22078966
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Reduction in acute myocardial infarction mortality over a five-year period].
    Heras M, Marrugat J, Arós F, Bosch X, Enero J, Suárez MA, Pabón P, Ancillo P, Loma-Osorio A, Rodríguez JJ, Subirana I, Vila J, en representación de los investigadores del estudio PRIAMHO.
    Rev Esp Cardiol; 2006 Mar 01; 59(3):200-8. PubMed ID: 16712743
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R, Wang Y, Foody JM.
    Am J Cardiol; 2008 Jan 15; 101(2):217-22. PubMed ID: 18178410
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Reduction in 28 days and 6 months of acute myocardial infarction mortality from 1995 to 2005. Data from PRIAMHO I, II and MASCARA registries].
    Arós F, Heras M, Vila J, Sanz H, Ferreira-González I, Permanyer-Miralda G, Cuñat J, López-Bescós L, Cabadés A, Loma-Osorio A, Marrugat J, en representación de los investigadores de los registros PRIAMHO I, II y MASCARA.
    Rev Esp Cardiol; 2011 Nov 15; 64(11):972-80. PubMed ID: 21803474
    [Abstract] [Full Text] [Related]

  • 54. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C, Jacobsen J, Larsen AC, Schmidt EB, Johannesen NL, Videbaek J, Sørensen HT, Johnsen SP.
    Eur J Vasc Endovasc Surg; 2008 Jan 15; 35(1):51-8. PubMed ID: 17923426
    [Abstract] [Full Text] [Related]

  • 55. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M, Richard H, Pilote L.
    Pharmacoepidemiol Drug Saf; 2007 Jul 15; 16(7):773-85. PubMed ID: 17486661
    [Abstract] [Full Text] [Related]

  • 56. [Beta blockers or ACE inhibitors following myocardial infarction in patients with diabetes?].
    Gystad K, Carlsen SM.
    Tidsskr Nor Laegeforen; 2000 Sep 10; 120(21):2565-9. PubMed ID: 11070998
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Chronic aspirin and statin therapy in patients with impaired renal function and acute coronary syndromes: results from the IN-ACS Outcome Registry.
    Sciahbasi A, Rizzello V, Gonzini L, Giampaoli S, Greco C, Di Pasquale G, Mureddu GF, Di Chiara A, Lioy E, Boccanelli A.
    Eur J Prev Cardiol; 2014 Feb 10; 21(2):214-21. PubMed ID: 22952286
    [Abstract] [Full Text] [Related]

  • 60. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
    Pereira M, Araújo C, Dias P, Lunet N, Subirana I, Marrugat J, Capewell S, Bennett K, Azevedo A.
    Eur J Prev Cardiol; 2014 Nov 10; 21(11):1401-8. PubMed ID: 23787795
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.